Literature DB >> 24660101

S100 protein family in human cancer.

Hongyan Chen1, Chengshan Xu1, Qing'e Jin1, Zhihua Liu1.   

Abstract

S100 protein family has been implicated in multiple stages of tumorigenesis and progression. Among the S100 genes, 22 are clustered at chromosome locus 1q21, a region frequently rearranged in cancers. S100 protein possesses a wide range of intracellular and extracellular functions such as regulation of calcium homeostasis, cell proliferation, apoptosis, cell invasion and motility, cytoskeleton interactions, protein phosphorylation, regulation of transcriptional factors, autoimmunity, chemotaxis, inflammation and pluripotency. Many lines of evidence suggest that altered expression of S100 proteins was associated with tumor progression and prognosis. Therefore, S100 proteins might also represent potential tumor biomarkers and therapeutic targets. In this review, we summarize the evidence connecting S100 protein family and cancer and discuss the mechanisms by which S100 exerts its diverse functions.

Entities:  

Keywords:  S100 proteins; apoptosis; biomarker; invasion; migration; pluripotency; proliferation

Year:  2014        PMID: 24660101      PMCID: PMC3960449     

Source DB:  PubMed          Journal:  Am J Cancer Res        ISSN: 2156-6976            Impact factor:   6.166


  290 in total

1.  Epithelial-mesenchymal transition, the tumor microenvironment, and metastatic behavior of epithelial malignancies.

Authors:  Lindsay J Talbot; Syamal D Bhattacharya; Paul C Kuo
Journal:  Int J Biochem Mol Biol       Date:  2012-05-18

2.  Prognostic impact of S100A9 overexpression in non-small cell lung cancer.

Authors:  Hideki Kawai; Yoshihiro Minamiya; Naoko Takahashi
Journal:  Tumour Biol       Date:  2011-03-03

3.  Stable knockdown of S100A4 suppresses cell migration and metastasis of osteosarcoma.

Authors:  Masahiko Fujiwara; Takeshi G Kashima; Akiko Kunita; Isao Kii; Daisuke Komura; Agamemnon E Grigoriadis; Akira Kudo; Hiroyuki Aburatani; Masashi Fukayama
Journal:  Tumour Biol       Date:  2011-03-01

4.  S100A6 overexpression is associated with poor prognosis and is epigenetically up-regulated in gastric cancer.

Authors:  Xiao-Hong Wang; Lian-Hai Zhang; Xi-Yao Zhong; Xiao-Fang Xing; Yi-Qiang Liu; Zhao-Jian Niu; Yong Peng; Hong Du; Gui-Guo Zhang; Ying Hu; Ni Liu; Yu-Bing Zhu; Shao-Hua Ge; Wei Zhao; Ai-Ping Lu; Ji-You Li; Jia-Fu Ji
Journal:  Am J Pathol       Date:  2010-06-25       Impact factor: 4.307

5.  Significance of S100A2 and S100A4 Expression in the Progression of Prostate Adenocarcinoma.

Authors:  Yong-Wook Kwon; In Ho Chang; Kyung Do Kim; Young Sun Kim; Soon-Chul Myung; Mi-Kyung Kim; Tae-Hyoung Kim
Journal:  Korean J Urol       Date:  2010-07-20

6.  Colorectal cancer progression correlates with upregulation of S100A11 expression in tumor tissues.

Authors:  Guiyu Wang; Xishan Wang; Shuhuai Wang; Hongtao Song; Haiming Sun; Weiguang Yuan; Bo Cao; Jing Bai; Songbin Fu
Journal:  Int J Colorectal Dis       Date:  2008-03-14       Impact factor: 2.571

Review 7.  Microenvironmental regulation of metastasis.

Authors:  Johanna A Joyce; Jeffrey W Pollard
Journal:  Nat Rev Cancer       Date:  2008-03-12       Impact factor: 60.716

8.  Expression profile of the S100 gene family members in oral squamous cell carcinomas.

Authors:  Dipak Sapkota; Ove Bruland; Olav E Bøe; Hala Bakeer; Osman A A Elgindi; Endre N Vasstrand; Salah O Ibrahim
Journal:  J Oral Pathol Med       Date:  2008-08-14       Impact factor: 4.253

9.  Expression of S100A2 calcium-binding protein predicts response to pancreatectomy for pancreatic cancer.

Authors:  Andrew V Biankin; James G Kench; Emily K Colvin; Davendra Segara; Christopher J Scarlett; Nam Q Nguyen; David K Chang; Adrienne L Morey; C-Soon Lee; Mark Pinese; Samuel C L Kuo; Johana M Susanto; Peter H Cosman; Geoffrey J Lindeman; Jane E Visvader; Tuan V Nguyen; Neil D Merrett; Janindra Warusavitarne; Elizabeth A Musgrove; Susan M Henshall; Robert L Sutherland
Journal:  Gastroenterology       Date:  2009-04-16       Impact factor: 22.682

10.  S100A2 induces metastasis in non-small cell lung cancer.

Authors:  Etmar Bulk; Bülent Sargin; Utz Krug; Antje Hascher; Yu Jun; Markus Knop; Claus Kerkhoff; Volker Gerke; Ruediger Liersch; Rolf M Mesters; Marc Hotfilder; Alessandro Marra; Steffen Koschmieder; Martin Dugas; Wolfgang E Berdel; Hubert Serve; Carsten Müller-Tidow
Journal:  Clin Cancer Res       Date:  2009-01-01       Impact factor: 12.531

View more
  93 in total

1.  PTCSC3 Is Involved in Papillary Thyroid Carcinoma Development by Modulating S100A4 Gene Expression.

Authors:  Jaroslaw Jendrzejewski; Andrew Thomas; Sandya Liyanarachchi; Andrew Eiterman; Jerneja Tomsic; Huiling He; Hanna S Radomska; Wei Li; Rebecca Nagy; Krzysztof Sworczak; Albert de la Chapelle
Journal:  J Clin Endocrinol Metab       Date:  2015-08-14       Impact factor: 5.958

2.  Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.

Authors:  Barbora Šumová; Lucie Andrés Cerezo; Lenka Szczuková; Lucie Nekvindová; Michal Uher; Hana Hulejová; Radka Moravcová; Mariam Grigorian; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt; Jakub Závada
Journal:  Rheumatol Int       Date:  2018-11-03       Impact factor: 2.631

3.  Identification of S100A14 as a metastasis-promoting molecule in a murine organotropic metastasis model.

Authors:  Takashi Sugino; Naoki Ichikawa-Tomikawa; Mizuko Tanaka; Namiko Shishito; Tomiko Miura; Masato Abe; Koji Muramatsu; Takuma Oishi; Yuko Kakuda; Takuya Kawata; Yasuto Akiyama
Journal:  Clin Exp Metastasis       Date:  2019-07-01       Impact factor: 5.150

4.  S100A11 is a potential prognostic marker for clear cell renal cell carcinoma.

Authors:  Manal Gabril; Hala Girgis; Andreas Scorilas; Fabio Rotondo; Samantha Wala; Georg A Bjarnason; Qiang Ding; Andrew Evans; Eriny Tawedrous; Maria Pasic; Antonio Finelli; Sahar Al-Haddad; George M Yousef
Journal:  Clin Exp Metastasis       Date:  2016-01       Impact factor: 5.150

5.  TLR4 and RAGE conversely mediate pro-inflammatory S100A8/9-mediated inhibition of proliferation-linked signaling in myeloproliferative neoplasms.

Authors:  Marijana Kovačić; Olivera Mitrović-Ajtić; Bojana Beleslin-Čokić; Dragoslava Djikić; Tijana Subotički; Miloš Diklić; Danijela Leković; Mirjana Gotić; Pascal Mossuz; Vladan P Čokić
Journal:  Cell Oncol (Dordr)       Date:  2018-06-26       Impact factor: 6.730

Review 6.  Control of cell mechanics by RhoA and calcium fluxes during epithelial scattering.

Authors:  Hillary J Haws; Melissa A McNeil; Marc D H Hansen
Journal:  Tissue Barriers       Date:  2016-05-11

7.  S100A14, a mediator of epithelial-mesenchymal transition, regulates proliferation, migration and invasion of human cervical cancer cells.

Authors:  Xiangyu Wang; Jing Yang; Jingfeng Qian; Zhihua Liu; Hongyan Chen; Zhumei Cui
Journal:  Am J Cancer Res       Date:  2015-03-15       Impact factor: 6.166

8.  S100A16 up-regulates Oct4 and Nanog expression in cancer stem-like cells of Yumoto human cervical carcinoma cells.

Authors:  Nariaki Tomiyama; Ryuji Ikeda; Yukihiko Nishizawa; Shogo Masuda; Yusuke Tajitsu; Yasuo Takeda
Journal:  Oncol Lett       Date:  2018-04-25       Impact factor: 2.967

Review 9.  Associations between single-nucleotide polymorphisms and inflammatory bowel disease-associated colorectal cancers in inflammatory bowel disease patients: a meta-analysis.

Authors:  H Li; Z Jin; X Li; L Wu; J Jin
Journal:  Clin Transl Oncol       Date:  2017-02-27       Impact factor: 3.405

Review 10.  Certainty of S100 from Physiology to Pathology.

Authors:  Puneeth Horatti Kuberappa; Bhavana Shivanand Bagalad; Anuradha Ananthaneni; Md Asif Kiresur; Guduru Vijay Srinivas
Journal:  J Clin Diagn Res       Date:  2016-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.